GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Eurofins-Cerep SA (XPAR:ALECR) » Definitions » LT-Debt-to-Total-Asset

Eurofins-Cerep (XPAR:ALECR) LT-Debt-to-Total-Asset : 0.00 (As of Jun. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Eurofins-Cerep LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Eurofins-Cerep's long-term debt to total assests ratio for the quarter that ended in Jun. 2024 was 0.00.

Eurofins-Cerep's long-term debt to total assets ratio increased from Jun. 2023 (0.00) to Jun. 2024 (0.00). It may suggest that Eurofins-Cerep is progressively becoming more dependent on debt to grow their business.


Eurofins-Cerep LT-Debt-to-Total-Asset Historical Data

The historical data trend for Eurofins-Cerep's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eurofins-Cerep LT-Debt-to-Total-Asset Chart

Eurofins-Cerep Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Eurofins-Cerep Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Eurofins-Cerep LT-Debt-to-Total-Asset Calculation

Eurofins-Cerep's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )=Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )/Total Assets (A: Dec. 2023 )
=0.003/79.249
=0.00

Eurofins-Cerep's Long-Term Debt to Total Asset Ratio for the quarter that ended in Jun. 2024 is calculated as

LT Debt to Total Assets (Q: Jun. 2024 )=Long-Term Debt & Capital Lease Obligation (Q: Jun. 2024 )/Total Assets (Q: Jun. 2024 )
=0.317/78.287
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Eurofins-Cerep  (XPAR:ALECR) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.


Eurofins-Cerep LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Eurofins-Cerep's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Eurofins-Cerep Business Description

Traded in Other Exchanges
N/A
Address
Le bois l Eveque, Celle l Evescault, FRA, 86600
Eurofins-Cerep SA provides in vitro pharmacology, in vitro ADME-Tox and in vivo PK services and solutions. The company also offers cost-effective drug discovery by identifying at early stages drug candidates and eliminating them. Some solutions provided by the company are - compound management, high-throughout screening, in vitro safety profiling, lead optimization profiling, in vitro ADME profiling, and in vivo PK.

Eurofins-Cerep Headlines

No Headlines